A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...
Hosted on MSN13h
The Antibiotic Arms Race: Can Science Stay Ahead of Rapidly Evolving Antibiotic-Resistant Bacteria?A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...
News Medical on MSN4d
RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancerA new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...
The National on MSN20h
Mosquitoes in UAE becoming resistant to key insecticideMosquitoes in the Emirates are becoming resistant to a key insecticide according to researchers at UAE University in Al Ain.
Along with researchers in the Faculty of Health Sciences and the Faculty of Science, Western projects received a total of $17 ...
Here, authors present FusOn-pLM, trained on FusOn-DB, which uses dynamic masking to outperform baselines in fusion-specific tasks and predict drug-resistant mutations, advancing therapeutic design.
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback